MRNA Income Statement
Moderna Inc - Revenue, Expenses & Profit Analysis
Stock Price
$0.00
Market Cap
-
Most Recent Quarter
Period: 2024-12-31(2024-12-31)
Revenue
Total sales from operations
$3.24B
-52.7% YoY
Net Income
Bottom line profit
$-3.56B
Earnings Per Share (Diluted)
Net income per share
$-9.28
Profitability Metrics
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2024-12-31 | $3.24B | - | - | $-3.56B | $-9.28 |
| 2023-12-31 | $6.85B | - | - | $-4.71B | $-12.33 |
| 2022-12-31 | $19.26B | - | - | $8.36B | $20.12 |
| 2021-12-31 | $18.47B | - | - | $12.20B | $28.29 |
| 2020-12-31 | $803.00M | - | - | $-747.00M | $-1.96 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is MRNA's revenue?
MRNA's most recent quarterly revenue was $3.24B, representing a decline of 52.7% year-over-year.
Is MRNA profitable?
MRNA reported a loss of $3.56B in the most recent quarter.
What is MRNA's operating income?
Operating income data is available in the income statement.
What is MRNA's earnings per share (EPS)?
MRNA reported diluted earnings per share of $-9.28 in the most recent quarter.
What is MRNA's gross profit margin?
Gross margin data is available in the profitability metrics section.